Evidence map›Paper›PMID 40034498›Full record

ArticleWestern Pacific surveillance and response journal : WPSAR

Sociobehavioural factors associated with SARS-CoV-2 infection and COVID-19 vaccine effectiveness against medically attended, symptomatic SARS-CoV-2 infection in the Philippines: a prospective case-control study (FASCINATE-P study).

Takeshi Arashiro, Regina Pascua Berba, Joy Potenciano Calayo, Marie Kris, Reby Marie Garcia, Shuichi Suzuki, Cecile Dungog, Jonathan Rivera, Greco Mark Malijan, Kristal An Agrupis and 6 more

Abstract read
In one paragraph

Article in Western Pacific surveillance and response journal : WPSAR. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Takeshi ArashiroFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom of Great Britain and Northern Ireland.
Regina Pascua BerbaHospital Infection Control Unit, Philippine General Hospital, Manila, Philippines.
Joy Potenciano CalayoDepartment of Laboratory, San Lazaro Hospital, Manila, Philippines.
Marie KrisSan Lazaro Hospital-Nagasaki University Collaborative Research Office and Laboratory, San Lazaro Hospital, Manila, Philippines.
Reby Marie GarciaSan Lazaro Hospital-Nagasaki University Collaborative Research Office and Laboratory, San Lazaro Hospital, Manila, Philippines.
Shuichi SuzukiSan Lazaro Hospital-Nagasaki University Collaborative Research Office and Laboratory, San Lazaro Hospital, Manila, Philippines.
Cecile DungogDepartment of Laboratories, Philippine General Hospital, Manila, Philippines.
Jonathan RiveraDepartment of Laboratories, Philippine General Hospital, Manila, Philippines.
Greco Mark MalijanSan Lazaro Hospital-Nagasaki University Collaborative Research Office and Laboratory, San Lazaro Hospital, Manila, Philippines.
Kristal An AgrupisSan Lazaro Hospital-Nagasaki University Collaborative Research Office and Laboratory, San Lazaro Hospital, Manila, Philippines.
Mary Jane SalazarSan Lazaro Hospital-Nagasaki University Collaborative Research Office and Laboratory, San Lazaro Hospital, Manila, Philippines.
Mary Ann SalazarSan Lazaro Hospital-Nagasaki University Collaborative Research Office and Laboratory, San Lazaro Hospital, Manila, Philippines.
Jinho ShinWorld Health Organization Regional Office for the Western Pacific, Manila, Philippines.
Martin HibberdFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom of Great Britain and Northern Ireland.
Koya AriyoshiSchool of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan.
Chris SmithFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom of Great Britain and Northern Ireland.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Objective: We examined sociobehavioural factors associated with SARS-CoV-2 infection and estimated COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection in the Philippines. Such studies are limited in low- and middle-income countries, especially in Asia and the Pacific. Methods: A case-control study was conducted in two hospitals in Manila, Philippines, from March 2022 to June 2023. Sociobehavioural factors and vaccination history were collected. PCR-positive individuals were cases, while PCR-negative individuals were controls. Adjusted odds ratios (aORs) were calculated to examine associations between sociobehavioural factors/vaccination and medically attended SARS-CoV-2 infection. Results: The analysis included 2489 individuals (574 positive cases, 23.1%; 1915 controls, 76.9%; median age [interquartile range]: 35 [27-51] years). Although education and household income were not associated with infection, being a health-care worker was (aOR: 1.45; 95% confidence interval [CI]: 1.03-2.06). The odds of infection were higher among individuals who attended gatherings of five or more people compared to those who attended smaller gatherings (aOR: 2.58; 95% CI: 1.14-5.83). Absolute vaccine effectiveness for vaccination status was not estimated due to a high risk of bias, for example, unascertained prior infection. Moderate relative vaccine effectiveness for the first booster (32%; 95% CI: -120-79) and the second booster (48%; 95% CI: -23-78) were observed (both with wide CI), albeit with a waning trend after half a year. Discussion: The higher odds of infection among health-care workers emphasize the importance of infection prevention and control measures. Moderate relative vaccine effectiveness with a waning trend reiterates the need for more efficacious vaccines against symptomatic infection caused by circulating variants and with longer duration of protection.

Indexed as

COVID-19COVID-19 VaccinesVaccine EfficacyAdultCase-Control StudiesFemaleHumansMaleMiddle AgedPhilippinesProspective StudiesSARS-CoV-2VaccinationCOVID-19 Vaccines

Identifiers

PMID40034498
PMCPMC11875425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.